REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinotherapeutics Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sinotherapeutics Inc. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sinotherapeutics Inc. is a specialty pharma focus on the R&D, registration, manufacturing, and commercialization of complex generic products as well as innovative formulation products. The company’s main products include Generic drugs and CRO/CMO Service. The company was established in 2012 and is headquartered in Shanghai City, China.

Headquarters
1st Floor, Building 3, No. 99 Haike Road, Pudong New Area, Shanghai
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Sinotherapeutics Inc. report to view the information.

Website: http://www.sinotherapeutics.com

Basic Information
Total Employees:
Purchase the Sinotherapeutics Inc. report to view the information.
Outstanding Shares:
Purchase the Sinotherapeutics Inc. report to view the information.
Registered Capital:
Purchase the Sinotherapeutics Inc. report to view the information.
Financial Auditors:
Purchase the Sinotherapeutics Inc. report to view the information.
Incorporation Date:
August 13, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
51.4%
Purchase this report to view the information.
15.54%
Purchase this report to view the information.
8.11%
Purchase this report to view the information.
3%
Purchase this report to view the information.
2.04%
Subsidiaries
GFW INC.
100%
Impact Biopharma Inc.
100%
Jiangsu Xuantai Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Sinotherapeutics Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
69.95%
Total operating revenue
67.33%
Operating profit (EBIT)
114.58%
Net Profit (Loss) for the Period
110.05%
Total assets
5.65%
Total equity
3.67%
Operating Profit Margin (ROS)
5.89%
Net Profit Margin
4.87%
Return on Equity (ROE)
3.79%
Quick Ratio
-0.72%
Cash Ratio
1.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?